Sign in

NCT04844502Completed

Cardiopulmonary Function and Quality of Life in Pulmonary Tuberculosis

Cardiopulmonary Function and Quality of Life in People With Sequelae of Pulmonary Tuberculosis Undergoing Pulmonary Rehabilitation: Controlled and Randomized Study.

Source: ClinicalTrials.gov · Last updated 11 May 2026

Brief summary (registry, in English)

This work aims to assess cardiopulmonary function and quality of life in people with sequelae of pulmonary tuberculosis undergoing rehabilitation. It is an experimental clinical study, with evaluation before and after the intervention. Included participants will be randomized and divided into a control group and an intervention group. Quality of life is examined by two questionnaires and physical fitness by specific tests, before and after the intervention. The intervention is the realization of a supervised physical exercise protocol.

Status (registry)
Completed
Study type
Interventional
Enrollment
60 (actual)
First submitted
10 Apr 2021
Start date
7 Apr 2021
Primary completion date
25 Oct 2025
Lead sponsor
Universidade Federal do Rio de Janeiro
Diseases
Tuberculosis
NCT number
NCT04844502

What you commit to

  • Study type: Interventional
  • Participants enrolled: 60
  • From 7 Apr 2021 to the primary completion date, 25 Oct 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • stable angina, severe arrhythmias and / or heart failure.

Other

  • Non-cooperative patients,
  • clinical instability and / or musculoskeletal injury that compromises Pulmonary Rehabilitation and limits the perception of physical capacity;
  • comorbidities that may cause or accentuate dyspnea (Asthma, COPD, Pulmonary Fibrosis, Obesity);

Who the study is looking for

  • Clinical diagnosis of Pulmonary Tuberculosis,
  • negative culture in induced sputum;
  • pulmonary function report (spirometry), chest X-ray and complete blood count with biochemistry updated in the last month,
  • in accordance with the Informed Consent Form.

Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University Hospital
Coordinator of this site? Confirm its status
Rio de JaneiroBrazilUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.